X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (80) 80
humans (71) 71
pharmacology & pharmacy (67) 67
female (56) 56
male (56) 56
adult (42) 42
middle aged (40) 40
pharmacogenetics (31) 31
pharmacokinetics (26) 26
analysis (23) 23
infectious diseases (23) 23
therapeutic drug monitoring (22) 22
genotype (21) 21
antiviral agents - therapeutic use (19) 19
polymorphism, single nucleotide (19) 19
retrospective studies (19) 19
hepatitis c, chronic - drug therapy (18) 18
ribavirin (16) 16
polymorphism, single nucleotide - genetics (14) 14
therapy (14) 14
treatment outcome (14) 14
virology (14) 14
microbiology (13) 13
ribavirin - therapeutic use (13) 13
hepatitis c virus (12) 12
interferon-alpha - therapeutic use (12) 12
genetic aspects (11) 11
hcv (11) 11
health aspects (11) 11
interleukins - genetics (11) 11
mass spectrometry (11) 11
methods (11) 11
care and treatment (10) 10
chromatography (10) 10
chromatography, high pressure liquid (10) 10
chromatography, high pressure liquid - methods (10) 10
chronic hepatitis-c (10) 10
hepatitis c, chronic - genetics (10) 10
interferon (10) 10
liquid chromatography (10) 10
p-glycoprotein (10) 10
abcb1 (9) 9
drug monitoring - methods (9) 9
genetic polymorphisms (9) 9
hepatitis c (9) 9
hepatitis c, chronic - virology (9) 9
infection (9) 9
iron overload (9) 9
plasma (9) 9
plasma - chemistry (9) 9
polymorphisms (9) 9
antiviral agents - pharmacokinetics (8) 8
biological response modifiers (8) 8
cohort studies (8) 8
drug therapy, combination (8) 8
hepacivirus - drug effects (8) 8
hiv (8) 8
metabolism (8) 8
tandem mass spectrometry (8) 8
aged (7) 7
anemia (7) 7
antiviral agents (7) 7
antiviral agents - blood (7) 7
chemistry, analytical (7) 7
child (7) 7
cyp24a1 (7) 7
efficacy (7) 7
hepacivirus - genetics (7) 7
hepatitis c - drug therapy (7) 7
hiv infections - drug therapy (7) 7
nitriles (7) 7
polyethylene glycols - therapeutic use (7) 7
prospective studies (7) 7
receptors, calcitriol - genetics (7) 7
recombinant proteins - therapeutic use (7) 7
ribavirin - adverse effects (7) 7
single nucleotide polymorphisms (7) 7
sustained virological response (7) 7
toxicology (7) 7
adolescent (6) 6
antiviral agents - administration & dosage (6) 6
antiviral agents - adverse effects (6) 6
beta-thalassemia (6) 6
beta-thalassemia - drug therapy (6) 6
child, preschool (6) 6
drug monitoring (6) 6
ferritin (6) 6
genetics & heredity (6) 6
hepatitis b (6) 6
hiv-infected patients (6) 6
human plasma (6) 6
il28b (6) 6
medical laboratory technology (6) 6
membrane transport proteins - genetics (6) 6
patients (6) 6
protease inhibitors (6) 6
pyrophosphatases - genetics (6) 6
quantification (6) 6
ribavirin - pharmacokinetics (6) 6
safety (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacokinetics, ISSN 0312-5963, 4/2017, Volume 56, Issue 4, pp. 355 - 369
Journal Article
Archives of Virology, ISSN 0304-8608, 4/2018, Volume 163, Issue 4, pp. 961 - 967
Mixed cryoglobulinemia (MC) is the most common extrahepatic manifestation of chronic hepatitis C (CHC), with the presence of symptoms in 10–15% of cases. There... 
Medical Microbiology | Infectious Diseases | Biomedicine | Virology | INFECTION | VIROLOGY | VASCULITIS | ANTIVIRAL THERAPY | Interferon | Biological response modifiers | Hepatitis C virus | Analysis | Ribavirin | Hepatitis | Cryoglobulinemia | Immunology | Immune response | Hepatitis C
Journal Article
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, ISSN 0305-1870, 02/2018, Volume 45, Issue 2, pp. 213 - 216
We evaluated the role of deferasirox therapeutic drug monitoring in order to avoid toxicity or treatment failure. Plasma concentrations, measured between two... 
OVERLOAD | iron overload | DIAGNOSIS | ferritin | PHYSIOLOGY | EFFICACY | TRANSFUSION-DEPENDENT ANEMIAS | IRON CHELATION-THERAPY | IMPROVED SURVIVAL | beta-thalassemia | creatinine | PEDIATRIC-PATIENTS | ICL670 | PHARMACOLOGY & PHARMACY | EXPERIENCE | therapeutic drug monitoring | Thalassemia | Ferritin | Creatinine | Body mass index | Body mass | Toxicity | Liver | Body size | Iron | Males | Patients | Monitoring
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 05/2017, Volume 69, Issue 5, p. 525
Iron chelation in the transfusion-dependent anaemias management is essential to prevent end-organ damage and to improve survival. Deferasirox is a once-daily... 
Anemia | Analysis | Chromatography
Journal Article
Journal Article
Journal of Pharmacy and Pharmacology, ISSN 0022-3573, 11/2016, Volume 68, Issue 11, p. 1417
Deferasirox adverse effects include the following: gastrointestinal disturbance, mild elevations in serum creatinine levels and intermittent proteinuria; these... 
Pharmacogenetics | Plasma physics | Chromatography | Ferritin | Toxicity | Drug dosages
Journal Article
Antiviral Therapy, ISSN 1359-6535, 2018, Volume 23, Issue 4, pp. 373 - 377
Background: Recently, due to its high effectiveness and tolerability, the treatment of chronic hepatitis B with entecavir became a standard practice. However,... 
INFECTIOUS DISEASES | THERAPY | PLASMA | VIROLOGY | EFFICACY | HBSAG LOSS | ANALOGS | UPLC-MS/MS METHOD | QUANTIFICATION | DECREASE | PHARMACOLOGY & PHARMACY
Journal Article
Journal Article